Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group (Q74194596)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 2000

Language	Label	Description	Also known as
English	Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group	scientific article published on 01 August 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

sclerosing cholangitis

1 reference

based on heuristic

inferred from title

primary sclerosing cholangitis

1 reference

based on heuristic

inferred from title

author name string

van Hoogstraten HJ

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Vleggaar FP

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Boland GJ

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

van Steenbergen W

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Griffioen P

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Hop WC

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

van Hattum J

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

van Berge Henegouwen GP

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Schalm SW

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

van Buuren HR

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

95

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

2015-2022

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.02267.X

21 January 2018

Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.02267.X

21 January 2018

Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.02267.X

21 January 2018

HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.02267.X

21 January 2018

Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.02267.X

21 January 2018

A comparison of budesonide with prednisolone for active Crohn's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.02267.X

21 January 2018

Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.02267.X

21 January 2018

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.02267.X

21 January 2018

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.02267.X

21 January 2018

Primary sclerosing cholangitis: findings on cholangiography and pancreatography

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.02267.X

21 January 2018

Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.02267.X

21 January 2018

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.02267.X

21 January 2018

A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.02267.X

21 January 2018

Identifiers

10.1111/J.1572-0241.2000.02267.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10950051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74194596&oldid=1755964333"